Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00124) | |||||
---|---|---|---|---|---|
Name |
Chlorpromazine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
chlorpromazine; Thorazine; 50-53-3; Largactil; Contomin; Chloropromazine; Chlorderazin; Aminazine; Chlorpromados; Fenactil; Megaphen; Propaphenin; Chlorpromazin; 2-Chloropromazine; Aminazin; Ampliactil; Fenaktyl; Largactyl; Phenactyl; Promactil; Promazil; Psychozine; Sanopron; Torazina; Wintermin; Elmarin; Esmind; Prozil; Chlor-Promanyl; Largactilothiazine; Clorpromazina; Novomazina; Fraction AB; 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine; Chlorpromazinum; Amplictil; SKF 2601-A; Cromedazine; Plegomasine; Aminasine; Amplicitil; HL 5746; 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-; BC 135; Chlor-PZ; Plegomazin; N-(3-Dimethylaminopropyl)-3-chlorophenothiazine; C17H19ClN2S; Chlorpromazine Tannate; HSDB 3033; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine; 4560 R.P.; UNII-U42B7VYA4P; Promapar; Propaphen; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine; CHEBI:3647; 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine; 2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina; CHEMBL71; 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine; 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine; Thorazine hydrochloride; U42B7VYA4P; Phenothiazine hydrochloride; Hibanil; Hibernal; Unitensen; NSC-167745; Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-; Phenothiazine, 2-chloro-10-[3-(dimethylamino)propyl]-; NCGC00015273-11; Thorazine Suppositories; DSSTox_CID_2808; Clorpromazina [Italian]; DSSTox_RID_76736; DSSTox_GSID_22808; Chlorpromazinium chloride; 4560 Rp hydrochloride; Chlorpromazinum [INN-Latin]; Clorpromazina [INN-Spanish]; [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine; Prazilpromactil; Chlordelazin; Phenathyl; [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine hydrochloride; CAS-50-53-3; Thorazine (TN); NSC17479; CCRIS 3711; NSC-226514; CAS-69-09-0; EINECS 200-045-8; Chlorpromazine (USP/INN); NSC 167745; Chlorpromazine cation radical; Chlropromados; Fraction; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]; JHICC02042; Chlorpromazine [USP:INN:BAN]; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]; SKF 2601A; SKF-2601; GG 407; Hibernal (Salt/Mix); Lomazine (Salt/Mix); Tranzine (Salt/Mix); Norcozine (Salt/Mix); Spectrum_000142; Prestwick0_000064; Prestwick1_000064; Prestwick2_000064; Prestwick3_000064; Spectrum2_001156; Spectrum3_000346; Spectrum4_000283; Spectrum5_000717; Lopac-C-8138; Biomol-NT_000020; Epitope ID:136898; GTPL83; 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+); SCHEMBL8321; 10-(3-Dimethylaminopropyl)-2-chlorophenothiazine; 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine; Lopac0_000249; Oprea1_110255; BSPBio_000247; BSPBio_002011; KBioGR_000806; KBioGR_002312; KBioSS_000622; KBioSS_002314; 34468-21-8; MLS003166901; DivK1c_000624; SPECTRUM1500184; 2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine; 6-(Dimethylamino)nicotinicacid; SPBio_001111; SPBio_002168; BPBio1_000273; BPBio1_001181; QSPL 401; DTXSID0022808; HMS501P06; KBio1_000624; KBio2_000622; KBio2_002312; KBio2_003190; KBio2_004880; KBio2_005758; KBio2_007448; KBio3_001231; KBio3_002792; SKF-2601A; ZINC44027; cMAP_000017; NINDS_000624; Bio1_000457; Bio1_000946; Bio1_001435; HMS1920M03; HMS2089C12; HMS2091E06; HMS3430C19; HMS3886G22; KUC112482N; Pharmakon1600-01500184; ALBB-022464; BCP03610; Tox21_110120; BBL028251; BDBM50001888; CCG-40059; MFCD00133295; NSC167745; NSC756661; NSC756689; STK182870; AKOS001490972; Tox21_110120_1; DB00477; J2.794D; KS-5101; MCULE-5976054678; NSC-756661; NSC-756689; RP-4560; SDCCGSBI-0050237.P005; IDI1_000624; QTL1_000021; NCGC00015273-01; NCGC00015273-02; NCGC00015273-03; NCGC00015273-04; NCGC00015273-05; NCGC00015273-06; NCGC00015273-07; NCGC00015273-08; NCGC00015273-09; NCGC00015273-10; NCGC00015273-12; NCGC00015273-13; NCGC00015273-14; NCGC00015273-15; NCGC00015273-16; NCGC00015273-17; NCGC00015273-19; NCGC00015273-31; NCGC00024409-04; NCGC00024409-05; NCGC00024409-06; NCGC00024409-07; NCGC00024409-08; KSC-315-032-; SMR001453710; 2-chloro-10-[3-(dimethylamino)propyl]-; SBI-0050237.P004; AB0015094; WLN: T C666 BN ISJ B3N1&1 EG; AB00051943; FT-0653683; 2601-A; C06906; D00270; J10069; M-1209; AB00051943-15; AB00051943-16; AB00051943_17; AB00051943_18; L000182; Q407972; SR-01000000012-5; SR-01000000012-6; 2-Chloro-10-(N-dimethylamino-n-propyl)-phenothiazine; BRD-K89997465-001-05-3; 1N,1N-dimethyl-3-(2-chloro-10H-10-phenothiazinyl)-1-propanamine; 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine #; (chloropromazine) [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine; (chlorpromazine)[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine; [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine (chlor-promazine); [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine( Chlorpromazine); [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine(clorpromazine); Chlorpromazine;[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Schizophrenia | ICD-11: 6A20 | [1] | ||
PubChem CID | |||||
Formula |
C17H19ClN2S
|
||||
Canonical SMILES |
CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
|
||||
InChI |
1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3
|
||||
InChIKey |
ZPEIMTDSQAKGNT-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=2726"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 318.9 | Topological Polar Surface Area | 31.8 | |
XlogP | 5.2 | Complexity | 339 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 4 | ||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Chlorpromazine 100 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Povidone; Acacia; Carnauba wax
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Contract Pharmacal; State of Florida DOH Central Pharmacy | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Povidone; Acacia; Carnauba wax; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals; Upsher-Smith Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack; Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Clinical Solutions Wholesale; TYA Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Titanium dioxide; Allyl sucrose; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health; Clinical Solutions Wholesale | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [8] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Chlorpromazine 200 mg tablet | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Povidone; Acacia; Carnauba wax
|
|||||
Dosage Form | Oral Tablet | |||||
Company | State of Florida DOH Central Pharmacy | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Titanium dioxide; Povidone; Acacia; Aluminum oxide; Carnauba wax; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Clinical Solutions Wholesale; TYA Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals; Upsher-Smith Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Clinical Solutions Wholesale | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Chlorpromazine 25 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Povidone; Acacia; Carnauba wax; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Povidone; Acacia; Carnauba wax
|
|||||
Dosage Form | Oral Tablet | |||||
Company | State of Florida DOH Central Pharmacy | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals; Upsher-Smith Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack; Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Clinical Solutions Wholesale; TYA Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health; Carilion Materials Management; Clinical Solutions Wholesale | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [8] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Povidone; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycols; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [8] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Chlorpromazine 50 mg tablet | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Povidone; Acacia; Carnauba wax
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Contract Pharmacal; State of Florida DOH Central Pharmacy | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Titanium dioxide; Povidone; Acacia; Carnauba wax; Sucralfate
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals; RemedyRepack; Upsher-Smith Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack; Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidones; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health; Clinical Solutions Wholesale | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [8] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Chlorpromazine 10 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital; Mylan Pharamceuticals; Upsher-Smith Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Anhydrous lactose; Sodium benzoate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Calcium sulfate, unspecified form; Ferrosoferric oxide; Sucrose; Titanium dioxide; Acacia; Aluminum oxide; Carnauba wax; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Povidone; Hydroxypropyl cellulose; Hypromellose 2208 (15000 cps); Polyethylene glycol; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [8] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.